Assetmark Inc. Cuts Stake in Tenet Healthcare Corporation $THC

Assetmark Inc. lowered its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 26.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,363 shares of the company’s stock after selling 2,346 shares during the period. Assetmark Inc.’s holdings in Tenet Healthcare were worth $1,292,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in THC. NewEdge Advisors LLC increased its stake in Tenet Healthcare by 6.1% in the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after acquiring an additional 166 shares during the last quarter. Jones Financial Companies Lllp increased its stake in Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after purchasing an additional 1,274 shares during the period. Sivia Capital Partners LLC bought a new stake in Tenet Healthcare during the 2nd quarter valued at about $290,000. Chicago Partners Investment Group LLC purchased a new stake in shares of Tenet Healthcare in the second quarter valued at approximately $273,000. Finally, Stephens Inc. AR purchased a new stake in shares of Tenet Healthcare in the 2nd quarter worth $306,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director directly owned 28,480 shares in the company, valued at $5,623,945.60. The trade was a 7.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.81% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on THC shares. KeyCorp upped their price target on shares of Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Thursday, February 12th. Wells Fargo & Company reissued an “overweight” rating and issued a $265.00 price target on shares of Tenet Healthcare in a report on Monday. Barclays boosted their price objective on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a report on Friday, February 13th. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Finally, Raymond James Financial set a $245.00 price target on Tenet Healthcare in a research report on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $246.71.

Tenet Healthcare Price Performance

NYSE:THC opened at $227.68 on Friday. The stock has a 50 day moving average of $201.26 and a two-hundred day moving average of $196.69. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $235.77. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. The firm has a market cap of $19.80 billion, a P/E ratio of 14.70, a price-to-earnings-growth ratio of 1.14 and a beta of 1.44.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s quarterly revenue was up 8.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.